Kwang‐Kuk Kim

1.5k total citations
47 papers, 961 citations indexed

About

Kwang‐Kuk Kim is a scholar working on Neurology, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Kwang‐Kuk Kim has authored 47 papers receiving a total of 961 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Neurology, 21 papers in Pathology and Forensic Medicine and 12 papers in Rheumatology. Recurrent topics in Kwang‐Kuk Kim's work include Peripheral Neuropathies and Disorders (20 papers), Multiple Sclerosis Research Studies (18 papers) and Autoimmune Neurological Disorders and Treatments (6 papers). Kwang‐Kuk Kim is often cited by papers focused on Peripheral Neuropathies and Disorders (20 papers), Multiple Sclerosis Research Studies (18 papers) and Autoimmune Neurological Disorders and Treatments (6 papers). Kwang‐Kuk Kim collaborates with scholars based in South Korea, United States and Sweden. Kwang‐Kuk Kim's co-authors include Young‐Min Lim, Eun‐Jae Lee, Hyunjin Kim, Eduardo E. Benarroch, Vanda A. Lennon, Joseph E. Parisi, Manfred W. Kilimann, Sean J. Pittock, Christina Stephan and Bahram Mokri and has published in prestigious journals such as PLoS ONE, Annals of Neurology and Scientific Reports.

In The Last Decade

Kwang‐Kuk Kim

44 papers receiving 931 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kwang‐Kuk Kim South Korea 18 726 338 152 131 126 47 961
Mark A. Hellmann Israel 16 616 0.8× 355 1.1× 152 1.0× 167 1.3× 135 1.1× 44 961
Tomomi Yonekawa Japan 16 443 0.6× 569 1.7× 197 1.3× 269 2.1× 212 1.7× 32 1.0k
Rosa Cortese Italy 17 538 0.7× 450 1.3× 74 0.5× 117 0.9× 128 1.0× 52 952
Byoung Joon Kim South Korea 23 806 1.1× 728 2.2× 171 1.1× 271 2.1× 283 2.2× 114 1.6k
Hannah Pellkofer Germany 16 574 0.8× 606 1.8× 80 0.5× 149 1.1× 199 1.6× 24 1.1k
Elisabetta Toffanin Italy 15 307 0.4× 136 0.4× 84 0.6× 153 1.2× 134 1.1× 21 707
Stefania Morino Italy 15 608 0.8× 474 1.4× 368 2.4× 67 0.5× 248 2.0× 48 1.1k
Aslı Kurne Türkiye 18 228 0.3× 284 0.8× 65 0.4× 124 0.9× 134 1.1× 60 746
Bernhard F. Décard Switzerland 19 709 1.0× 189 0.6× 488 3.2× 55 0.4× 142 1.1× 38 1.2k
Bernardo Sánchez‐Dalmau Spain 19 258 0.4× 606 1.8× 76 0.5× 218 1.7× 198 1.6× 71 1.2k

Countries citing papers authored by Kwang‐Kuk Kim

Since Specialization
Citations

This map shows the geographic impact of Kwang‐Kuk Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kwang‐Kuk Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kwang‐Kuk Kim more than expected).

Fields of papers citing papers by Kwang‐Kuk Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kwang‐Kuk Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kwang‐Kuk Kim. The network helps show where Kwang‐Kuk Kim may publish in the future.

Co-authorship network of co-authors of Kwang‐Kuk Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Kwang‐Kuk Kim. A scholar is included among the top collaborators of Kwang‐Kuk Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kwang‐Kuk Kim. Kwang‐Kuk Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huh, So‐Young, Su‐Hyun Kim, Ki Hoon Kim, et al.. (2022). Safety and Temporal Pattern of the Lymphocyte Count During Fingolimod Therapy in Patients With Multiple Sclerosis: Real-World Korean Experience. Journal of Clinical Neurology. 18(6). 663–663. 3 indexed citations
2.
Kim, Hyunjin, Eun‐Jae Lee, Young‐Min Lim, & Kwang‐Kuk Kim. (2022). Glial Fibrillary Acidic Protein in Blood as a Disease Biomarker of Neuromyelitis Optica Spectrum Disorders. Frontiers in Neurology. 13. 865730–865730. 26 indexed citations
3.
Kim, Hyunjin, et al.. (2020). Anti-CASPR2-Antibody-Positive Isaacs' Syndrome Presenting with Myokymia, Neuropathic Pain, and Hyperhidrosis. Journal of Clinical Neurology. 16(4). 699–699. 4 indexed citations
4.
Lim, Young‐Min, et al.. (2020). Beneficial effects of intravenous immunoglobulin as an add-on therapy to azathioprine for NMO-IgG-seropositive neuromyelitis optica spectrum disorders. Multiple Sclerosis and Related Disorders. 42. 102109–102109. 8 indexed citations
5.
Lee, Eun‐Jae, Young‐Min Lim, Hyunjin Kim, et al.. (2020). Clinical implication of serum biomarkers and patient age in inflammatory demyelinating diseases. Annals of Clinical and Translational Neurology. 7(6). 992–1001. 31 indexed citations
6.
Kim, Hyunjin, Young‐Min Lim, Geonwoo Kim, et al.. (2020). Choroid plexus changes on magnetic resonance imaging in multiple sclerosis and neuromyelitis optica spectrum disorder. Journal of the Neurological Sciences. 415. 116904–116904. 20 indexed citations
7.
8.
Kim, Hyunjin, et al.. (2019). Efficacy and safety of alemtuzumab in Korean multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 30. 247–251. 6 indexed citations
9.
Kim, Jee‐Eun, Jin Myoung Seok, Suk-Won Ahn, et al.. (2019). Basic concepts of needle electromyography. 21(1). 7–7. 3 indexed citations
10.
Lee, Eun‐Jae, et al.. (2018). The clinical and prognostic value of antinuclear antibodies in NMO-IgG seropositive neuromyelitis optica spectrum disorder. Journal of Neuroimmunology. 328. 1–4. 19 indexed citations
11.
Kim, Hyunjin, et al.. (2018). Factors predicting remission in thymectomized patients with acetylcholine receptor antibody‐positive myasthenia gravis. Muscle & Nerve. 58(6). 796–800. 21 indexed citations
12.
Lim, Young‐Min, et al.. (2016). Clinical presentation, imaging findings, and prognosis of spinal dural arteriovenous fistula. Journal of Clinical Neuroscience. 26. 105–109. 33 indexed citations
13.
Chung, Sun Ju, Kwang‐Kuk Kim, Dong‐Wha Kang, et al.. (2014). Emotional Disturbance in CADASIL: Its Impact on Quality of Life and Caregiver Burden. Cerebrovascular Diseases. 37(3). 188–194. 28 indexed citations
14.
Lim, Young‐Min, et al.. (2012). Small fiber function in drug naïve patients with idiopathic restless legs syndrome. Journal of Clinical Neuroscience. 19(5). 702–705. 14 indexed citations
15.
Kim, Heeyoung, Young‐Min Lim, & Kwang‐Kuk Kim. (2009). Anti-Ri-Antibody-Associated Paraneoplastic Syndrome in a Man with Breast Cancer Showing a Reversible Pontine Lesion on MRI. Journal of Clinical Neurology. 5(3). 151–151. 14 indexed citations
16.
Kim, Kwang‐Kuk. (2007). Multiple Sclerosis. Journal of Korean Medical Association. 50(3). 252–252.
17.
Han, Seung‐Ho, Hyun‐Sook Chi, Kwang‐Kuk Kim, et al.. (2005). A Case of Paraneoplastic Limbic Encephalitis presenting Anti-Purkinje Cell Antibody. Journal of the Korean Neurological Association. 23(5). 724–726. 2 indexed citations
18.
Pittock, Sean J., Claudia F. Lucchinetti, Joseph E. Parisi, et al.. (2005). Amphiphysin autoimmunity: Paraneoplastic accompaniments. Annals of Neurology. 58(1). 96–107. 238 indexed citations
19.
Suh, Dae Chul, Choong Gon Choi, Kyu Bo Sung, Kwang‐Kuk Kim, & Seung Chul Rhim. (2004). Spinal osseous epidural arteriovenous fistula with multiple small arterial feeders converging to a round fistular nidus as a target of venous approach.. American Journal of Neuroradiology. 25(1). 69–73. 44 indexed citations
20.
Yu, Zhiya, Thomas J. Kryzer, Guy E. Griesmann, et al.. (2001). CRMP‐5 neuronal autoantibody: Marker of lung cancer and thymoma‐related autoimmunity. Annals of Neurology. 49(2). 146–154. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark A. Hellmann Breakdown of academic impact, for papers by Tomomi Yonekawa Breakdown of academic impact, for papers by Rosa Cortese Breakdown of academic impact, for papers by Byoung Joon Kim Breakdown of academic impact, for papers by Hannah Pellkofer Breakdown of academic impact, for papers by Elisabetta Toffanin Breakdown of academic impact, for papers by Stefania Morino Breakdown of academic impact, for papers by Aslı Kurne Breakdown of academic impact, for papers by Bernhard F. Décard Breakdown of academic impact, for papers by Bernardo Sánchez‐Dalmau
Rankless by CCL
2026